Business Wire Feed
Aditxt Acquires Ignite Proteomics to Address a Critical Challenge in Cancer Care: Optimizing Therapy Selection
Ignite plans to launch a new program in 2026 supporting treatment selection for more than 600,000 people in the United States living with metastatic cancer and limited therapeutic options.MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Aditxt, Inc. (NASDAQ: ADTX) more...
New Guardant Health/Harris Poll Survey Shows 92% of All Eligible Americans Believe Colorectal Cancer Blood Tests Should be Accessible and Covered Similar to Medicare
Survey highlights barriers to colorectal cancer screening for adults 45 and over Overwhelming majority (92%) of Americans ages 45 and over believe blood-based screening should be covered with no co-pay Shield™ by Guardant is proven more...
P3 Health Partners Schedules Fourth Quarter and Full Year 2025 Earnings Release and Conference Call
HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced that the Company plans to release its financial results for fourth quarter and more...
Alto Neuroscience Announces Participation at the Stifel 2026 Virtual CNS Forum
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--$anro #cns--Alto Neuroscience, Inc. (“Alto”) (NYSE: ANRO) a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, today announced that members of the Company’s management team will more...
bioAffinity Technologies Announces Record 2025 Revenue and Unit Sales for Flagship Lung Cancer Diagnostic CyPath® Lung
Laboratory business streamlined in 2025 to focus on profitable diagnostic testing services including the Company’s high-value CyPath® Lung test Number of CyPath® Lung tests performed in 2025 increased by 99% compared to 2024 Orders for more...
KORU Medical Systems Announces EU MDR Certification for the Freedom60® Infusion Pump With Prefilled Syringe Compatibility
MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today more...
Form Health Joins the Lilly Employer Connect Platform
This program supports flexible, more transparent, predictable access to obesity management medications for employers and their employeesBOSTON--(BUSINESS WIRE)--Form Health, the national leader in science-based obesity and cardiometabolic care, today announced it has joined Eli Lilly more...
Weave Named Exclusive Patient Engagement Platform Endorsed for American Dental Association Members
LEHI, Utah--(BUSINESS WIRE)--#GetWeave--Weave (NYSE: WEAV), a leading all-in-one customer experience platform for small and medium-sized healthcare businesses, today announced it has been selected as the exclusive patient engagement platform endorsed for members of the American more...
TIXiMED Announces Expansion of Program-Related Investment from the Helmsley Charitable Trust
Expanded Charitable Funding will Support Phase 1 Multiple Ascending Dose Trial and Long-Term Toxicology Studies for TIX100, a Novel Oral Therapy Targeting Beta Cell Health in Type 1 DiabetesBIRMINGHAM, Ala.--(BUSINESS WIRE)--TIXiMED, Inc., a clinical-stage pharmaceutical more...
AIDS Groups Protest City-Planned Cuts to HIV/AIDS Care in Chicago
Nonprofit organizations team together to halt cuts to HIV primary care by the Department of Health; AHF, South Side Help Center, and CALOR to also give testimony at HIV Planning Committee Emergency Meeting Friday, March more...
Aptar Pharma and COVIRIX Medical Partner to Develop Inhalable Antiviral Treatments
CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar Pharma, a global leader in drug delivery, dosing, protection technologies and services, today announced a technical collaboration with COVIRIX Medical Pty Ltd (“COVIRIX Medical”), an Australian biopharma company under a Letter more...
HealthPartners commentary illustrates the paradox of modern, knowledge-based work
A lack of opportunities for movement throughout the day can undermine brain performance; author provides practical ways leaders can adopt movement-at-work as a business strategy.BLOOMINGTON, Minn.--(BUSINESS WIRE)--A commentary from HealthPartners Institute published in the Journal more...
AV Laboratories Appoints Dr. Dendy Engelman to Scientific Advisory Board
NEW YORK--(BUSINESS WIRE)--#AVL--AV Laboratories, a biotechnology-driven skincare brand focused on clinical longevity, today announced the appointment of Dr. Dendy Engelman, MD, FACMS, FAAD, to its Scientific Advisory Board. A board-certified dermatologist and Mohs surgeon, Dr. more...
Stevanato Group to Participate in the KeyBanc Capital Markets Virtual Healthcare Forum
PIOMBINO DESE, Italy--(BUSINESS WIRE)--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced today that it will participate in more...
Laird Superfood Completes Acquisition of Navitas LLC
Supported by $50 Million Investment from Nexus Capital Management LPBOULDER, Colo.--(BUSINESS WIRE)--#coffee--Laird Superfood, Inc. (NYSE American: LSF) (“Laird Superfood,” “Laird” or the “Company”), today announced the completion of its previously announced acquisition of all of more...
Phreesia’s Tiffany McGee Named a Top Woman Leader in Software
ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia, a leader in patient intake, outreach and activation, is proud to announce that Tiffany McGee, Assistant General Counsel, Commercial Contracts, has been named to The Software Report’s 2025 list of the more...
Insulet Initiates Voluntary Medical Device Correction for Certain Omnipod® 5 Pods in the U.S.
Medical Device Correction impacts only specific lots of Omnipod® 5 Pods Customers can visit omnipod.com/check-pods to check lot numbers and request replacement Pods at no cost All other Omnipod® 5 Pods and Omnipod® products remain more...
Beren Therapeutics Presents Data Supporting the Efficacy of Adrabetadex in Infantile-Onset NPC at 2026 ACMG Clinical Genetics Meeting
-- Treatment with adrabetadex reduced the annual rate of neurologic disease progression by 43%, in addition to previously reported substantial improvements in overall survival, among individuals with infantile-onset NPC -- Biomarker data show improved intracellular more...
Blackstone Trial Group Launches as the Nation’s Premier Law Firm Dedicated Exclusively to Correctional Healthcare Defense
New firm brings focused expertise to defending healthcare professionals serving incarcerated populationsBIRMINGHAM, Ala. & DALLAS--(BUSINESS WIRE)--Blackstone Trial Group, PLLC today announced its official launch as a specialized litigation firm focused exclusively on defending correctional healthcare more...
eClinical Solutions Appoints Lauren Whitsell as Chief Operating Officer and Venu Mallarapu as Chief Transformation and AI Officer
Supporting 18 of the top 50 pharmaceutical companies in the world with its industry-leading clinical data intelligence platform, the company eyes its next phase of growth with expanded C-suiteBOSTON--(BUSINESS WIRE)--eClinical Solutions LLC, a global provider more...
Virta Health’s Nutrition Therapy Extends Survival by 34% in Stage IV Pancreatic Cancer Patients, New Clinical Trial Shows
Virta’s nutritional intervention shown to improve survival outcomes in randomized, controlled Phase II clinical trial on patients with one of the deadliest cancersDENVER--(BUSINESS WIRE)--Virta Health, the leader in reversing metabolic disease, announced today results from more...
DeepTech Company Zander Labs Enters the U.S. Market With Groundbreaking pBCI Technology
Zander Labs to actively seek U.S. partners for integration of neuroadaptive technology in 2026BERLIN & SAN FRANCISCO--(BUSINESS WIRE)--Zander Labs, a Dutch-German neuroadaptive AI company focused on passive brain-computer interfaces (pBCI) and human-computer interactive technology, is more...
Foundation Medicine Launches Whole Genome Sequencing Germline Test for Research Use to Accelerate Biopharmaceutical Research and Therapy Development Beyond Oncology
Whole Genome Sequencing (WGS) test now available through Foundation Medicine’s FlexOMx Lab™ to support biomarker discovery and drug development across cardiometabolic, immunologic and neurologic disease areasBOSTON--(BUSINESS WIRE)--Foundation Medicine, Inc., a global precision medicine company, today more...
Alkermes Announces Inaugural Alkermes Pathways APN Research Awards™ Program
— Competitive Grant Program to Offer Individual Grants of Up to $10,000 per Project — — Inaugural Application Cycle Open to Licensed Psychiatric-Mental Health Nurse Practitioners Across Multiple Clinical Settings — — Application Period to more...
Baseimmune Announces Strategic Expansion into Fibrosis with Lead Program Targeting Idiopathic Pulmonary Fibrosis (IPF)
Baseimmune unveils a new multi-pathway immunotherapy strategy, applying its computational protein design platform to develop next-generation therapies for fibrosis. Fibrosis is driven by complex and redundant biological pathways, limiting the effectiveness of single-target approaches. Baseimmune more...